EMA Recommends Extension of Therapeutic Indications for Denosumab

Change in indications considers prevention of skeletal related events in adults with advanced malignancies involving bone

Read full article (External website)

1 reply

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply